课题基金 / 基金详情

Non-communicable disease epidemiology and public health

Non-communicable disease epidemiology and public health
非传染性疾病流行病学和公共卫生
批准号:
ES/N013891/1
负责人:
Nicholas Wareham
金额:
$19.36万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2015
资助国家:
英国
项目状态:
已结题
起止时间:
2015 至 --

项目摘要

项目成果

Nicholas Wareham的其他基金

相似基金

相关文献

中文摘要
翻译
营养不足和感染仍然是非洲国家的主要公共卫生问题,但糖尿病、心血管疾病和癌症等非传染性疾病正在加剧这些问题,这些疾病以前在发达国家更常见。预计到2030年,这些疾病将成为非洲最常见的死亡原因。糖尿病在世界上许多国家的发病率正在上升,但据估计,非洲的增长速度是世界上最快的,预计到2035年,非洲将有超过4000万人患有这种疾病。与世界其他国家一样,非洲非传染性疾病增加的主要驱动因素是饮食和体力活动行为的变化以及不同生命阶段肥胖的发展。然而,推动这些行为变化的因素在不同国家是不同的。这些因素超越了个人的态度和选择,决定了食品供应、成本和可获得性、工作性质和建筑环境的结构。发展对这些更广泛因素的了解是确定这些公共卫生挑战的可能解决方案过程中必要的一部分。这一国际博士合作计划建立在剑桥大学和约翰内斯堡威特沃特斯兰德大学之间现有的机构联系基础上。这两个牵头部门的目标都是通过研究和开发干预措施来改善公共卫生,以降低生命周期中关键发育时期的慢性病风险。该方案将具体旨在通过将南非研究人员与联合王国饮食和活动研究中心(CEDAR)联系起来,制定旨在人口一级解决非传染性疾病流行病的工作;该中心是一个多学科的公共卫生研究卓越中心,旨在增进对人口饮食和活动行为决定因素的了解,并评估人口干预措施。
英文摘要
Under-nutrition and infection remain major public health problems in African countries, but are being added to by non-communicable diseases (NCDs) such as diabetes, cardiovascular disease and cancer, conditions that have previously been seen more frequently in developed countries. These conditions are expected to become the most common cause of death in Africa by 2030. Diabetes is rising in frequency in many countries around the world, but the rate of increase in Africa is estimated to be the fastest anywhere and more than 40 million Africans are predicted to have the disease by 2035. The main drivers of this rise in NCDs in Africa, in common with other countries around the world, are changes in dietary and physical activity behaviour and the development of obesity at different stages of life. However, the factors that are driving these changes in behavior are different between countries. These go beyond individuals' attitudes and choices to factors that determine the food supply, its cost and availability, the nature of work and the structure of built environment. The development of understanding of these wider factors is a necessary part of the process of identifying possible solutions to these public health challenges.This International PhD partnering scheme builds on existing institutional links between the University of Cambridge and the University of Witwatersrand, Johannesburg. The two lead departments both aim to improve public health by researching and developing interventions to reduce the risk of chronic disease at critical developmental periods across the lifespan. The programme will specifically aim to develop work aimed at population-level solutions to the epidemic of non-communicable diseases by linking South African researchers to the United Kingdom Centre of Diet and Activity Research (CEDAR); a multi-disciplinary centre of public health research excellence aiming to develop understanding about the population determinants of diet and activity behaviour and to evaluate population interventions.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1186/s40814-021-00802-6
发表时间: 2021-02-27
期刊: Pilot and feasibility studies
影响因子: 1.7
作者: [Klingberg S, van Sluijs EMF, Jong ST, Draper CE]
通讯作者: Draper CE
DOI: 10.1017/s1368980020003730
发表时间: 2021-08
期刊: Public health nutrition
影响因子: 3.2
作者: [Klingberg S, van Sluijs EM, Draper CE]
通讯作者: Draper CE
Director of population health improvement network of clusters
  • 批准号:
    MR/Y033914/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $650.43万
  • 财政年份:
    2024
  • 负责人:
    Nicholas Wareham
  • 依托单位:
Developing and disseminating tools for population health improvement: an online interactive atlas for identifying environmental change
  • 批准号:
    MC_PC_21024
  • 项目类别:
    Intramural
  • 资助金额:
    $25.48万
  • 财政年份:
    2022
  • 负责人:
    Nicholas Wareham
  • 依托单位:
The EPIC-Norfolk Study
  • 批准号:
    MC_PC_21036
  • 项目类别:
    Intramural
  • 资助金额:
    $79.51万
  • 财政年份:
    2021
  • 负责人:
    Nicholas Wareham
  • 依托单位:
Aetiology and Mechanisms of Diabetes and Related Metabolic Disorders of Later Life
  • 批准号:
    MC_UU_00006/1
  • 项目类别:
    Intramural
  • 资助金额:
    $764.77万
  • 财政年份:
    2020
  • 负责人:
    Nicholas Wareham
  • 依托单位:
海外基金